Warren Hirsch's most recent trade in ProPhase Labs Inc was a trade of 100,000 Option (right to buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProPhase Labs Inc | Warren Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 100,000 | 100,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Warren Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2024 | 70,000 | 70,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Warren Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 40,000 | 40,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Warren Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 40,000 | 40,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Warren Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 50,000 | 50,000 | - | - | Option (right to buy) |